瑞康医药(002589.SZ)：累计回购2.31%股份 回购方案已实施完毕

Core Viewpoint - 瑞康医药 has completed its share repurchase plan, acquiring a total of 34,638,659 shares, which represents 2.31% of the company's total share capital [1] Summary by Categories Share Repurchase Details - The company repurchased shares through a centralized bidding transaction method, with a total payment amounting to RMB 101,475,367.91 (excluding transaction fees) [1] - The highest transaction price was 3.08 RMB per share, while the lowest was 2.75 RMB per share [1] - The repurchase period spanned from February 14, 2025, to November 6, 2025 [1] Compliance and Implementation - The total amount spent on the repurchase has reached the lower limit of the planned repurchase funds and has not exceeded the upper limit [1] - The repurchase prices did not exceed the upper limit set in the repurchase plan [1] - The repurchase complies with relevant laws and regulations and aligns with the established share repurchase plan [1]